PD-1 inhibitors for urothelial cancer: combination or sequential therapy? - Authors' reply
- PMID: 33341140
- DOI: 10.1016/S0140-6736(20)32675-1
PD-1 inhibitors for urothelial cancer: combination or sequential therapy? - Authors' reply
Comment on
-
PD-1 inhibitors for urothelial cancer: combination or sequential therapy?Lancet. 2021 Dec 19;396(10267):1977. doi: 10.1016/S0140-6736(20)32672-6. Lancet. 2021. PMID: 33341141 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical